©The Author(s) 2025.
World J Gastrointest Oncol. Oct 15, 2025; 17(10): 108410
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.108410
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.108410
Figure 4 The mRNA expression levels of enhancer of zeste homolog 2, methyltransferase-like 3, SRY-box transcription factor 4, B-cell lymphoma 2, and Bax in different cell groups.
A: Enhancer of zeste homolog 2 mRNA expression level; B: Methyltransferase-like 3 mRNA expression level; C: SRY-box transcription factor 4 mRNA expression level; D: B-cell lymphoma 2 mRNA expression level; E: Bax mRNA expression level. aP < 0.0001; cP < 0.0001; bP < 0.05; dP < 0.0001; eP < 0.0001. SOX4: SRY-box transcription factor 4; METTL3: Methyltransferase-like 3; EZH2: Enhancer of zeste homolog 2; Bcl2: B-cell lymphoma 2; NC: Negative control; YGS: Yigong San; OE: Overexpressing.
- Citation: Wang J, Zhang XW, Tang BW, Li Z, Song N. Molecular mechanism of modified Yigong San formula against colorectal cancer via EZH2/METTL3/SOX4 pathway-mediated apoptosis. World J Gastrointest Oncol 2025; 17(10): 108410
- URL: https://www.wjgnet.com/1948-5204/full/v17/i10/108410.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i10.108410